Patent · US Active

Antisense antibacterial compounds and methods

US10907158B2 · kind B2 · utility

0Cited by
21References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 22, 2016
Grant dateFeb 2, 2021
Priority date
Expiry dateDec 22, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are antisense morpholino oligomers targeted against bacterial virulence factors such as genes that contribute to antibiotic resistance or biofilm formation, or essential genes, and related compositions and methods of using the oligomers and compositions, for instance, in the treatment of an infected mammalian subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.